Document is current
Any future updates will be listed below
-
Authors
Freyer, Oscar
Buch, Stephan
Bassily-Marcus, Adel
Zenker, Sven
Pickering, Brian W.
Ostermann, Max
Schönfelder, Anett
Gilbert, Stephen
-
Funding
Funding for this research was provided by:
European Commission (101094218)
Bundesministerium für Forschung, Technologie und Raumfahrt (03ZU1210BA)
- License Information
-
More Information
Article History
Received: 10 January 2026
Accepted: 26 March 2026
First Online: 10 April 2026
Competing interests
: The authors declare the following competing interests: O.F. has a leadership role and holds stock in WhalesDontFly GmbH, and has had consulting relationships with Prova Health Ltd. O.F. has received honoraria from the European Society of Medical Oncology (ESMO). O.F. is an Associated Editor for npj Digital Medicine. S.G. is an advisory group member of the Ernst & Young-coordinated “Study on Regulatory Governance and Innovation in the field of Medical Devices” conducted on behalf of the Directorate-General for Health and Food Safety of the European Commission. S.G. has or has had consulting relationships with Una Health GmbH, Lindus Health Ltd, Flo Ltd, Thymia Ltd, FORUM Institut für Management GmbH, High-Tech Gründerfonds Management GmbH, and Ada Health GmbH, and he holds share options in Ada Health GmbH. S.G. is a News and Views Editor for npj Digital Medicine. S.Z. serves as chair of the Expert Panel on Medical Devices “Respiratory system, anesthesiology, intensive care” for the European Medicines Agency/European Commission. All other authors declare no competing interests.
